BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32187017)

  • 1. Electrochemotherapy in treatment of canine oral malignant melanoma and factors influencing treatment outcome.
    Tellado MN; Maglietti FH; Michinski SD; Marshall GR; Signori E
    Radiol Oncol; 2020 Mar; 54(1):68-78. PubMed ID: 32187017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrochemotherapy in treatment of canine oral non-tonsillar squamous cell carcinoma. A case series report.
    Simčič P; Lowe R; Granziera V; Pierini A; Torrigiani F; Lubas G
    Vet Comp Oncol; 2020 Sep; 18(3):428-432. PubMed ID: 31419028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Mucosa Model for Electrochemotherapy Treatment of Dog Mouth Cancer: Ex Vivo, In Silico, and In Vivo Experiments.
    Suzuki DOH; Berkenbrock JA; Frederico MJS; Silva FRMB; Rangel MMM
    Artif Organs; 2018 Mar; 42(3):297-304. PubMed ID: 29027689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of electrochemotherapy, gene electrotransfer of plasmid encoding canine IL-12 and cytoreductive surgery in the treatment of canine oral malignant melanoma.
    Milevoj N; Tratar UL; Nemec A; Brožič A; Žnidar K; Serša G; Čemažar M; Tozon N
    Res Vet Sci; 2019 Feb; 122():40-49. PubMed ID: 30453179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation.
    Proulx DR; Ruslander DM; Dodge RK; Hauck ML; Williams LE; Horn B; Price GS; Thrall DE
    Vet Radiol Ultrasound; 2003; 44(3):352-9. PubMed ID: 12816381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA.
    Riccardo F; Iussich S; Maniscalco L; Lorda Mayayo S; La Rosa G; Arigoni M; De Maria R; Gattino F; Lanzardo S; Lardone E; Martano M; Morello E; Prestigio S; Fiore A; Quaglino E; Zabarino S; Ferrone S; Buracco P; Cavallo F
    Clin Cancer Res; 2014 Jul; 20(14):3753-62. PubMed ID: 24874834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor.
    Grosenbaugh DA; Leard AT; Bergman PJ; Klein MK; Meleo K; Susaneck S; Hess PR; Jankowski MK; Jones PD; Leibman NF; Johnson MH; Kurzman ID; Wolchok JD
    Am J Vet Res; 2011 Dec; 72(12):1631-8. PubMed ID: 22126691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local control and distant metastasis after electrochemotherapy of a canine anal melanoma.
    Spugnini EP; Filipponi M; Romani L; Dotsinsky I; Mudrov N; Baroni A; Ruocco E; Laieta MT; Montesarchio V; Cassandro R; Citro G; Baldi A
    In Vivo; 2007; 21(5):897-9. PubMed ID: 18019432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrochemotherapy compared to surgery for treatment of canine mast cell tumours.
    Kodre V; Cemazar M; Pecar J; Sersa G; Cor A; Tozon N
    In Vivo; 2009; 23(1):55-62. PubMed ID: 19368125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse-mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma.
    Spugnini EP; Dragonetti E; Vincenzi B; Onori N; Citro G; Baldi A
    Melanoma Res; 2006 Feb; 16(1):23-7. PubMed ID: 16432452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma.
    Ottnod JM; Smedley RC; Walshaw R; Hauptman JG; Kiupel M; Obradovich JE
    Vet Comp Oncol; 2013 Sep; 11(3):219-29. PubMed ID: 23909996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT.
    Kunte C; Letulé V; Gehl J; Dahlstroem K; Curatolo P; Rotunno R; Muir T; Occhini A; Bertino G; Powell B; Saxinger W; Lechner G; Liew SH; Pritchard-Jones R; Rutkowski P; Zdzienicki M; Mowatt D; Sykes AJ; Orlando A; Mitsala G; Rossi CR; Campana L; Brizio M; de Terlizzi F; Quaglino P; Odili J;
    Br J Dermatol; 2017 Jun; 176(6):1475-1485. PubMed ID: 28118487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision.
    Dank G; Rassnick KM; Sokolovsky Y; Garrett LD; Post GS; Kitchell BE; Sellon RK; Kleiter M; Northrup N; Segev G
    Vet Comp Oncol; 2014 Mar; 12(1):78-84. PubMed ID: 22737988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK.
    Verganti S; Berlato D; Blackwood L; Amores-Fuster I; Polton GA; Elders R; Doyle R; Taylor A; Murphy S
    J Small Anim Pract; 2017 Jan; 58(1):10-16. PubMed ID: 28094857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome following curative-intent surgery for oral melanoma in dogs: 70 cases (1998-2011).
    Tuohy JL; Selmic LE; Worley DR; Ehrhart NP; Withrow SJ
    J Am Vet Med Assoc; 2014 Dec; 245(11):1266-73. PubMed ID: 25406707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases.
    Giacobino D; Camerino M; Riccardo F; Cavallo F; Tarone L; Martano M; Dentini A; Iussich S; Lardone E; Franci P; Valazza A; Manassero L; Del Magno S; De Maria R; Morello E; Buracco P
    Vet Comp Oncol; 2021 Dec; 19(4):651-660. PubMed ID: 33751759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of spontaneous canine mast cell tumors by electrochemotherapy combined with IL-12 gene electrotransfer: Comparison of intratumoral and peritumoral application of IL-12.
    Lampreht Tratar U; Milevoj N; Cemazar M; Znidar K; Ursic Valentinuzzi K; Brozic A; Tomsic K; Sersa G; Tozon N
    Int Immunopharmacol; 2023 Jul; 120():110274. PubMed ID: 37216797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional implant for treatment of primary oral malignant melanoma in dogs.
    Kitchell BE; Brown DM; Luck EE; Woods LL; Orenberg EK; Bloch DA
    J Am Vet Med Assoc; 1994 Jan; 204(2):229-36. PubMed ID: 8144382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.
    Piras LA; Riccardo F; Iussich S; Maniscalco L; Gattino F; Martano M; Morello E; Lorda Mayayo S; Rolih V; Garavaglia F; De Maria R; Lardone E; Collivignarelli F; Mignacca D; Giacobino D; Ferrone S; Cavallo F; Buracco P
    Vet Comp Oncol; 2017 Sep; 15(3):996-1013. PubMed ID: 27146852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
    Brockley LK; Cooper MA; Bennett PF
    N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.